chrisvoncsefalvay/vaers-outcomes huggingface dataset:
patient was able to stick a magnet to the injection site/magnetic effects at the injection; This is a spontaneous report from a contactable consumer (patient's wife) via medical information team. A male patient (spouse) of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry dates were not provided), via an unspecified route of administration, on 11May2021 as SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was able to stick a magnet to the injection site/magnetic effects at the injection site on an unspecified date. The outcome of the event unknown.  No follow-up attempts are possible. No further information is expected. ; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021634416 Same reporter/drug/event, different patients
dizzy; couldn't sleep Saturday night; once or twice felt really hot; joint pain; nauseous; on and off chills still happening; tired; possible fever; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), INSOMNIA (couldn't sleep Saturday night), FEELING HOT (once or twice felt really hot), ARTHRALGIA (joint pain) and NAUSEA (nauseous) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B2HA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMIN D NOS for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced DIZZINESS (dizzy), INSOMNIA (couldn't sleep Saturday night), FEELING HOT (once or twice felt really hot), ARTHRALGIA (joint pain), NAUSEA (nauseous), CHILLS (on and off chills still happening), FATIGUE (tired) and PYREXIA (possible fever). At the time of the report, DIZZINESS (dizzy), INSOMNIA (couldn't sleep Saturday night), FEELING HOT (once or twice felt really hot), ARTHRALGIA (joint pain), NAUSEA (nauseous), CHILLS (on and off chills still happening), FATIGUE (tired) and PYREXIA (possible fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information for the events was provided.
No adverse event; Pharmacist called to report that she administered MMR-II to a patient who received immunoglobulins about 2 to 3 weeks ago. Type of immunoglobulin unknown by reporter. Unknown dates of administration at time of call. Limited patient demographics and l; This spontaneous report was received from a pharmacist, concerning a non-identifiable patient of unknown age and gender.  The patient's medical history, concurrent conditions, drug reactions or allergies and concomitant therapies were not reported.  On an unknown date in 2023, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), once, (dose, lot #, expiry date, route of administration, and anatomical location were not provided) administered for prophylaxis to a patient who had received immunoglobulins about 2 to 3 weeks ago (type of immunoglobulin was unknown by reporter) (contraindicated product administered).  No adverse event was reported.  Follow-up information was received from a pharmacist on 04-AUG-2023.The case has become valid as the pharmacist stated the patient is female.
I was instructed to stay for 30min as i have been anaphylatic to cipro in past. at 30min was told i could leave. while driving home on rt 91 my cheekbones became numb. then slowly a few min later my cheeks became numb. a few min later my lips became numb. as i was driving off exit to rt 5 in longmeadow i developed a lump in my throat. i turned around at top of exit and went back to highway to go to ER. this was approx 1645-1650. i went to ER arrived approx 1655. i was shaking. my bp and pulse were elevated. no tingling or swelling in my face. nurse checked my pupils and my smile and were wnl. no history of bells palsy. i received iv fluids, solucortef 125mg ivp, pepcid 20mg ivp, and benedryl 25mg ivp approx 1840pm. approx 45 min after solucortef numbness better but not gone. it started to come back a little more before discharge, which i let md know. she discharged me with scripts for epi-pen, prednisone, and OTC pepcid and benedryl. follow up with my pcp's office in am 12/24 at 10am with his NP. total time with facial numbness/lip numbness 29 hours.
The patient received expired Moderna COVID-19 vaccine for his first booster; The vial was expired on 23-Mar-2022 and stored in refrigerator on 16-May-2022 before administration on 20-May-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patient received expired Moderna COVID-19 vaccine for his first booster) and PRODUCT STORAGE ERROR (The vial was expired on 23-Mar-2022 and stored in refrigerator on 16-May-2022 before administration on 20-May-2022) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030H21B and 020F21A) for COVID-19 vaccination.     Concurrent medical conditions included Immunosuppression (Immunosuppresssion due to drug therapy).   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-May-2022, the patient experienced PRODUCT STORAGE ERROR (The vial was expired on 23-Mar-2022 and stored in refrigerator on 16-May-2022 before administration on 20-May-2022). On 20-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient received expired Moderna COVID-19 vaccine for his first booster). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The patient received expired Moderna COVID-19 vaccine for his first booster) and PRODUCT STORAGE ERROR (The vial was expired on 23-Mar-2022 and stored in refrigerator on 16-May-2022 before administration on 20-May-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The reporter occupation was provided as a pharmacy technician. The patient had received third full Moderna COVID-19 vaccine dose. No concomitant medications were reported. It was reported that the nurse had a lot number of older vaccine and expiration date was 23-Mar-2022. This was inadvertently mixed in with other Moderna COVID-19 vaccines with newer lot numbers and that were still within their manufacturer expiration dates. The vial was initially stored in the refrigerator on 16-May-2022. The vial had not undergone any temperature excursions. No adverse reactions or other side effects were noted.  No treatment medications were reported.
Information has been received from a consumer concerning her son, a 11 year old male with no pertinent medical history, drug reactions or allergies who on 15-SEP-2010 was vaccinated with the first dose of 0.5 ml GARDASIL (lot # 666163/0664Z), concomitantly with a 0.5 ml ADACEL (Lot # C3486AA) and a 0.5 ml MENACTRA (lot # U3443BA). The GARDASIL was given at the same site as one of the other vaccines, but the consumer did not know which one. On approximately 16-SEP-2010 (the Thursday or Friday after the vaccination), the patient developed "what seemed like an unusual amount of redness and swelling at the GARDASIL injection site. The patient said that he saw little water filled blisters at the injection site." Her neighbor was a pediatrician who looked at it and said that "the swelling was from the vaccination." No laboratory diagnostics studies were performed. The therapy was not reintroduced. At the time of reporting, the patient was recovering from events after stopping therapy. Additional information has been requested.
Patient felt fine but had a large bruise about 3 inches in diameter on his arm where he recieved the injection.  He did not complain of any pain. Patient did not recieve any treatment here. Told patient that if the bruise got larger or spread that he should contact his physician.  The bruise lasted for about 2 weeks but then cleared up.
injection site pain; chest pain; chills; a little fatigue; a slight headache; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pain), CHILLS (chills), FATIGUE (a little fatigue), HEADACHE (a slight headache) and INJECTION SITE PAIN (injection site pain) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012F21A, 026L20A and 013L20A) for COVID-19 vaccination.     Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID], CARVEDILOL, ATORVASTATIN CALCIUM, LISINOPRIL and AMLODIPINE for an unknown indication.   On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Oct-2021, the patient experienced CHILLS (chills), FATIGUE (a little fatigue) and HEADACHE (a slight headache). On 30-Oct-2021, the patient experienced CHEST PAIN (chest pain). On an unknown date, the patient experienced INJECTION SITE PAIN (injection site pain). On 30-Oct-2021, CHEST PAIN (chest pain) had resolved. At the time of the report, CHILLS (chills), FATIGUE (a little fatigue), HEADACHE (a slight headache) and INJECTION SITE PAIN (injection site pain) outcome was unknown.            Treatment details not provided.   This case was linked to MOD-2021-369033, MOD-2021-369048 (Patient Link).
about 4 months after having the booster patient got two blood clots in leg; This spontaneous case was reported by a consumer and describes the occurrence of THROMBOSIS (about 4 months after having the booster patient got two blood clots in leg) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Prostate surgery in September 2021. Previously administered products included for COVID-19 vaccination: Johnson and Johnson vaccine on 15-Mar-2021. Past adverse reactions to the above products included No adverse event with Johnson and Johnson vaccine. Concurrent medical conditions included Cancer.    In 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THROMBOSIS (about 4 months after having the booster patient got two blood clots in leg) (seriousness criterion medically significant). At the time of the report, THROMBOSIS (about 4 months after having the booster patient got two blood clots in leg) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Ultrasound scan: blood clots Blood clots were there for a long time..         Concomitant drugs were not reported. Treatment medications were not provided.   It was reported that patient received the JNJ vaccine last February 2021 and Moderna vaccine around July or August 2021 and did not know exact dates or have lot information. Caller stated the technician who did the ultrasound said the blood clots were there for a long time.  Company comment: This spontaneous case concerns an elderly male patient (age not specified) with relevant medical history of cancer, which is unspecified and prostate surgery, who experienced the unexpected serious AESI Thrombosis, approximately four months after the booster dose of mRNA-1273. The patient experienced two blood clots in leg' and the ultrasound confirmed on the same having blood clots. No further details were reported. The event outcome was unknown. Medical history of cancer which is unspecified could be the risk factor. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This spontaneous case concerns an elderly male patient (age not specified) with relevant medical history of cancer, which is unspecified and prostate surgery, who experienced the unexpected serious AESI Thrombosis, approximately four months after the booster dose of mRNA-1273. The patient experienced two blood clots in leg' and the ultrasound confirmed on the same having blood clots. No further details were reported. The event outcome was unknown. Medical history of cancer which is unspecified could be the risk factor. The benefit-risk relationship of mRNA-1273 is not affected by this report.
Began having a red inflamed rash on left neck and upper chest.  Had been taking claritin since vaccine secondary to previous large itchy inflamed rash from send Maderna dose.  Within minutes bottom of right eye began getting red and hurting and vision seemed to have gotten worse. Call opthamologist and was told to come in the next morning.  Eye exam showed vision loss in right eye.
Hives and pruritis, H1 and H2 blockers, +/- Medrol pak if needed.
Patient received vaccinations and sat for 5 minutes. When she got up to leave she said she was gonna throw up. I laid her down on exam table. She felt better BP 120/71. BP sitting up 110/61 and BP standing 101/64. She drank a cup of water and ate crackers since she hadn't eaten since breakfast. I walked her to her car and told her to go eat something and if symptoms worsen go to ER.
Information has been received from a physician concerning a female patient who was vaccinated with one doses of GARDASIL, date of dose unknown, lot # was not reported. The patient experienced breakthrough bleeding after getting GARDASIL. Unspecified medical attention had been sought. This is one of several reports received from the same source. Additional information has been requested.
57 days since first dose on 2Feb2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (57 days since first dose on 2Feb2021) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012MZ0A) for COVID-19 vaccination.     Concurrent medical conditions included COPD (COPD), Asthma (Asthma) and Emphysema (Emphysema). Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), SERTRALINE HYDROCHLORIDE (ZOLOFT), ARIPIPRAZOLE (ABILIFY), OMEPRAZOLE (PROTONIX [OMEPRAZOLE]), ATORVASTATIN CALCIUM (LIPITOR) and MONTELUKAST SODIUM (SINGULAIR) for an unknown indication.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (57 days since first dose on 2Feb2021). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (57 days since first dose on 2Feb2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Other concomitant medications were included inhalers and vitamins No Treatment medication were reported.   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: TCR: Dose 2 vaccine received by the patient.
After vaccination on the 3rd day I was making my bed and when I pulled the covers back i fell over and couldn't control my legs,  it happened later that day and the next morning. There was no pain or numbness just loss of control of my legs like they were not there, but I could move my feet.  The facility sent me to another hospital and they did X-ray, and listened to my heart.
Noticed rash and hives on my arms especially inside forearms that come and go on day 7. It?s now day 21 and it still comes and goes everyday. My throat or airway also feel like it?s trying to close up.  My lips are also  swollen from time to time and feel  warmer than usual.  My stomach area has also been itchy also with my ankles and  sometimes the inside of my legs. Also the ears are red and my back had also itches . When I scratch any area it swells to something more abnormal and turns into hives. I have taken Benadryl and Zyrtec it doesn?t seem to help much   I have no insurance and can not afford to go to the dr. Please help me.
Approx 36 hrs after vaccine - cramping in legs - burning on feet (soles) - rhinitis - post - nasal drip (severe) Temp - 100.6 - 101.8 - still febrile - severe bronchitis - NASONEX - azelastine spray - TUSSINEX cough syrup LEVAQUIN 500 mg - prednisone 500 mg/day - TYLENOL 1 q 4 hours .
Dizzy spells, not provoked with position change occurring at least once an hour lasting for several seconds
This case was reported by a pharmacist via call center representative and described the occurrence of injection site swelling in a 73-year-old male patient who received SHINGRIX (batch number HG4P3, expiry date 13th July 2020). Concomitant products included SINGULAIR. On 5th May 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 6th May 2018, 1 days after receiving SHINGRIX, the patient experienced injection site swelling, injection site rash and injection site erythema. On an unknown date, the outcome of the injection site swelling, injection site rash and injection site erythema were unchanged. The reporter considered the injection site swelling, injection site rash and injection site erythema to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX in the left arm. The patient experienced redness, swelling and rash at the injection site which was about the size of a palm. All questions were asked.
She had a fever at night on 6/5/07. She stated that "her rt arm where she received the Varivax on 6/4/07, the area was red, swollen and painful."
caller had first dose of her vaccine on 4/6th and the next is due on 4/29th. On the given card it does not say if it was Moderna or Pfizer.  2 days ago, pt noticed swelling on the upper palm of her left hand, applying ice helps.  Also c/o uncomfortable gas on her sternum, taking omeprazole has helped. Now it comes and goes.  She has not changed any eating habit changes. She is afraid of blood clots in her system.    Health Authority: described delayed effects are unlikely to be related to the Vaccine. Seek md/attention if symptoms persists.  Since the next dose is scheduled after 23days after her 1st dose, it suggests she was given the Pfizer vaccine.  When going for the 2nd dose make sure you get name and LOT# written on the card. Call back w/q.
Full arm became swollen, red, warm to the touch, mimicking a cellulitis-looking infection.  Redness was spreading to left lateral neck and across upper chest.  Took 50mg chewable Benadryl and 600mg motrin.  All symptoms subsided approximately an hour later.
THE ADVERSE EFFECTS WERE FROM LACK OF VACCINATION DUE TO SERIOUS MISINFORMATION.
This patient was admitted to the Hospital on 12/31/2021 for COVID related symptoms. This is considered a breakthrough case.
Pt c/o abnormal sensation to lips (as if swollen) and throat scratchy. Ongoing X 3 days at time of visit; HPV vaccine 5 days prior to visit. VS: T 98.5, RR 16, HR 60, BP 121/65, O2 98%. Pt well appearing. Airway patent. TX: prednisone and advised BENADRYL. Advised F/U allergist.
6 x 6cm area of erythema and induration to left anterior thigh at injection site with extended area of erythema (extending toward inner thigh) measuring a total of 10cm - no palp inguinal nodes, no systemic symptoms
Vaccinated for Covid -19 and admitted to hospital 1/11/22  with Covid
This spontaneous report as received from a female patient of unknown age regarding herself. On an unknown date the patient was vaccinated with ZOSTAVAX. On an unknown date, the patient experienced unspecified adverse experiences since receiving ZOSTAVAX (date and location unspecified). The reporter declined to participate in any reporting and only wanted medical advice. The outcome of adverse experiences unspecified was unknown. Additional information has been requested.
3/19/2021 FEVER, CHILLS, BRAIN FOG. 3/23/2021: URTICARIA GENERALIZED
PT DEVELOPED MACULOPAPULAR RASH 1/19 ON FACE THAT SPREAD TO TRUNK AND ARMS AND LEGS TODAY.  ITCHY.
Initial report received from a healthcare professional on 13-Sep-2013. A 15-months-old infant was administered with ADACEL instead of DAPTACEL as the 4th dose. (No information was provided regarding the patient). No adverse event was reported. List of documents held by sender: none.
experiencing soreness in upper arms bilaterally; difficulty sleeping last night; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP). Other Case identifier(s): EC-2021-103486.  A female patient received bnt162b2 (BNT162B2), administration date 04Nov2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation; influenza vaccine (INFLUENZA VACCINE), administration date 04Nov2021 (Batch/Lot number: unknown) as dose number unknown, single for immunisation. Relevant medical history included: "endometrial carcinoma" (unspecified if ongoing), notes: Diagnosis C54.1. Concomitant medication(s) included: LENVIMA taken for endometrial cancer, start date: 22Oct2021. Past drug history included: Keytruda infusion, notes: Infusion. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "experiencing soreness in upper arms bilaterally"; INSOMNIA (non-serious), outcome "unknown", described as "difficulty sleeping last night". Therapeutic measures were taken as a result of pain in extremity.  Additional information: Patient began Lenvima 20 mg once daily on 10/22/21. Since start of therapy, patient has experienced tongue sensitivity. Stated tongue is sensitive to hot temperature and mint in mouthwash. Unknown date of onset of symptoms. Patient stated also received COVID-19 booster and influenza vaccine on 11/4/21. Since that time has been experiencing soreness in upper arms bilaterally. Stated had difficulty sleeping last night secondary to pain. Spoke with oncologist's office and advised okay to take Motrin for pain. Diagnosis C54.1 Endometrial Carcinoma, Lenvima 20 mg once daily, start date 10/22/21 Relevant history includes endometrial carcinoma, Keytruda infusion.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a licensed practical nurse via company representative, refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. The patient received 2 doses of MMR II (dose, route, lot# and expiration date were not reported) on unspecified dates. The patient's titers were measured an unspecified amount of time after the two doses of MMR II had been administered. The patient's titers were negative for measles, but positive for mumps and rubella. The outcome of negative titers for measles was not reported. The relatedness between the event and MMR II was not provided. Additional information has been requested.